255 related articles for article (PubMed ID: 30098670)
21. Facilitators and Barriers to Oncologists' Conduct of Goals of Care Conversations.
Schulman-Green D; Lin JJ; Smith CB; Feder S; Bickell NA
J Palliat Care; 2018 Jul; 33(3):143-148. PubMed ID: 29790421
[TBL] [Abstract][Full Text] [Related]
22. A preliminary survey of oncologists' perceptions of quality of life information.
Bezjak A; Ng P; Taylor K; MacDonald K; Depetrillo AD
Psychooncology; 1997 Jun; 6(2):107-13. PubMed ID: 9205968
[TBL] [Abstract][Full Text] [Related]
23. Do oncologists believe new cancer drugs offer good value?
Nadler E; Eckert B; Neumann PJ
Oncologist; 2006 Feb; 11(2):90-5. PubMed ID: 16476830
[TBL] [Abstract][Full Text] [Related]
24. Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventions.
Greenberg D; Hammerman A; Vinker S; Shani A; Yermiahu Y; Neumann PJ
Value Health; 2013; 16(5):842-7. PubMed ID: 23947979
[TBL] [Abstract][Full Text] [Related]
25. "Often Relatives are the Key […]" -Family Involvement in Treatment Decision Making in Patients with Advanced Cancer Near the End of Life.
Laryionava K; Hauke D; Heußner P; Hiddemann W; Winkler EC
Oncologist; 2021 May; 26(5):e831-e837. PubMed ID: 33037846
[TBL] [Abstract][Full Text] [Related]
26. Recommendations for hospice care to terminally ill cancer patients: a phenomenological study of oncologists' experiences.
Marmo S
J Soc Work End Life Palliat Care; 2014; 10(2):149-69. PubMed ID: 24835384
[TBL] [Abstract][Full Text] [Related]
27. Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs.
Daroudi R; Mirzania M; Zendehdel K
Int J Health Policy Manag; 2015 Oct; 5(2):99-105. PubMed ID: 26927395
[TBL] [Abstract][Full Text] [Related]
28. Patients' and oncologists' views on family involvement in goals of care conversations.
Lin JJ; Smith CB; Feder S; Bickell NA; Schulman-Green D
Psychooncology; 2018 Mar; 27(3):1035-1041. PubMed ID: 29315989
[TBL] [Abstract][Full Text] [Related]
29. OpenNotes in oncology: oncologists' perceptions and a baseline of the content and style of their clinician notes.
Alpert JM; Morris BB; Thomson MD; Matin K; Geyer CE; Brown RF
Transl Behav Med; 2019 Mar; 9(2):347-356. PubMed ID: 29596633
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.
Puts MT; Sattar S; McWatters K; Lee K; Kulik M; MacDonald ME; Jang R; Amir E; Krzyzanowska MK; Leighl N; Fitch M; Joshua AM; Warde P; Tourangeau AE; Alibhai SM
Support Care Cancer; 2017 Mar; 25(3):879-886. PubMed ID: 27830393
[TBL] [Abstract][Full Text] [Related]
31. Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
Mohile SG; Magnuson A; Pandya C; Velarde C; Duberstein P; Hurria A; Loh KP; Wells M; Plumb S; Gilmore N; Flannery M; Wittink M; Epstein R; Heckler CE; Janelsins M; Mustian K; Hopkins JO; Liu J; Peri S; Dale W
J Natl Compr Canc Netw; 2018 Mar; 16(3):301-309. PubMed ID: 29523669
[No Abstract] [Full Text] [Related]
32. Oncologists' Views Regarding the Role of Electronic Health Records in Care Coordination.
Asan O; Nattinger AB; Gurses AP; Tyszka JT; Yen TWF
JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652555
[TBL] [Abstract][Full Text] [Related]
33. Utilization of genomic testing in advanced non-small cell lung cancer among oncologists in the Veterans Health Administration.
Arney J; Helm A; Crook T; Braun UK; Chen GJ; Hayes TG
Lung Cancer; 2018 Feb; 116():25-29. PubMed ID: 29413047
[TBL] [Abstract][Full Text] [Related]
34. Oncologist, patient, and companion questions during pretreatment consultations about adjuvant cancer treatment: a shared decision-making perspective.
Pieterse AH; Kunneman M; Engelhardt EG; Brouwer NJ; Kroep JR; Marijnen CAM; Stiggelbout AM; Smets EMA
Psychooncology; 2017 Jul; 26(7):943-950. PubMed ID: 27502561
[TBL] [Abstract][Full Text] [Related]
35. Exploring the Routine Administration of Decision Aids for Palliative Chemotherapy to Patients by Nurses: A Qualitative Study Among Nurses and Oncologists.
Oostendorp LJ; Ottevanger PB; van der Graaf WT; Peters ME; Hermens RP; Stalmeier PF
Cancer Nurs; 2015; 38(4):270-8. PubMed ID: 25101927
[TBL] [Abstract][Full Text] [Related]
36. Mixed-Methods Study of the Impact of Chronic Patient Death on Oncologists' Personal and Professional Lives.
Granek L; Ariad S; Nakash O; Cohen M; Bar-Sela G; Ben-David M
J Oncol Pract; 2017 Jan; 13(1):e1-e10. PubMed ID: 28084882
[TBL] [Abstract][Full Text] [Related]
37. Are radiation oncologists aware of health literacy among people with cancer treated with radiotherapy?
Smith SK; Petrak LM; Dhillon HM; Taylor J; Milross CG
Eur J Cancer Care (Engl); 2014 Jan; 23(1):111-20. PubMed ID: 23957463
[TBL] [Abstract][Full Text] [Related]
38. Medical oncologists' perception of palliative care programs and the impact of name change to supportive care on communication with patients during the referral process. A qualitative study.
Rhondali W; Burt S; Wittenberg-Lyles E; Bruera E; Dalal S
Palliat Support Care; 2013 Oct; 11(5):397-404. PubMed ID: 23302500
[TBL] [Abstract][Full Text] [Related]
39. "Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.
Schildmann J; Tan J; Salloch S; Vollmann J
Oncologist; 2013; 18(1):90-6. PubMed ID: 23287883
[TBL] [Abstract][Full Text] [Related]
40. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
